On March 29, CDC revised its list of conditions that put an individual at high risk for severe COVID-19 disease, meaning the patient may require hospitalization, intensive care, a ventilator to help with breathing, or could even die.

It is well established that long-term use of high doses of NSAIDs can cause kidney injury, especially in older adults. This association has been criticized, however, because it is based only on serum creatinine-based glomerular filtration rate (GFR) estimates. A recent study published in the March issue of the Journal of the American Geriatrics Society investigated the association of NSAID use with kidney damage in older adults using multiple kidney health measures.

With the country on the cusp of a potential fourth surge in coronavirus infections, President Biden on Monday urged state officials to reinstate masking requirements. "This is not politics," he said.

FDA has approved idecabtagene vicleuce (Abecma—Celgene), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or whose disease has returned after, at least four prior lines (different types) of therapy. It is the first cell-based gene therapy approved by FDA for the treatment of multiple myeloma.

Telehealth has been a welcomed service for both patients and health care providers during the COVID-19 pandemic, but a new study published in the American Journal of Preventive Medicine found that these services were mostly accessed by those living in affluent and metropolitan areas.